首页 | 本学科首页   官方微博 | 高级检索  
检索        


Pharmacotherapy for erectile dysfunction
Authors:Tom FLue  Keith LLee
Institution:Department of Urology,School of Medicine, University of California, San Francisco, California, USA;Department of Urology, University of California, San Francisco, California, USA
Abstract:Objective To review current pharmacologic treatment options for erectile dysfunction.Methods Relevant literatures from the past two decades regarding the following treatments were reviewed: intracavernous injection, topical therapy, transurethral therapy and oral drugs.Study selection More than 125 originally identified articles were reviewed, and 45 were selected that especially addressed the stated purpose.Results Among the pharmacologic treatment options available, intracavernous injection therapy remains the most effective although the drop-out rate is high.Topical creams and gels have not been very successful.Transurethral alprostadil can be more effective if a constriction device is applied at the base of the penis.Oral sildenafil has the highest patient acceptance rate although systemic side effects can be a major drawback.Conclusions Effective pharmacotherapies for ED of various etiologies are now available.However, proper evaluation of every patient should be performed before giving treatment so that a number of potentially life-threatening causes of erectile dysfunction would not be missed.
Keywords:erectile dysfunction  prostaglandin E1  sildenafil  oral agent
点击此处可从《中华医学杂志(英文版)》浏览原始摘要信息
点击此处可从《中华医学杂志(英文版)》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号